E6201 gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E6201 gel, covering 2021-06-11 to 2021-06-11. Get the full timeline:
Most recent: Clinical Trial Update: A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris [Phase 2]